Literature DB >> 27718015

Steroid-responsive hyperammonemic encephalopathy as first manifestation of multiple myeloma.

Alessandra Gaiani1, Sara Pompanin1, Renato Zambello2, Chiara Briani1, Annachiara Cagnin3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27718015     DOI: 10.1007/s10072-016-2730-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  6 in total

1.  Bortezomib, cyclophosphamide, and dexamethasone: highly effective for rapid reversal of myeloma-associated hyperammonemic encephalopathy.

Authors:  Rebecca Howman; Arti Thakerer; Matthew Pitman; Nik Ding; Philip A Thompson; Amit Khot; Simon J Harrison
Journal:  Leuk Lymphoma       Date:  2010-10-07

2.  Hyperammonemia and encephalopathy in patients with multiple myeloma.

Authors:  Giampaolo Talamo; Federica Cavallo; Maurizio Zangari; Bart Barlogie; Choon-Kee Lee; Mauricio Pineda-Roman; Elias Kiwan; Somashekar Krishna; Guido Tricot
Journal:  Am J Hematol       Date:  2007-05       Impact factor: 10.047

3.  Urea cycle disorders: a life-threatening yet treatable cause of metabolic encephalopathy in adults.

Authors:  Nicholas F Blair; Philip D Cremer; Michel C Tchan
Journal:  Pract Neurol       Date:  2014-08-14

4.  Development of hyperammonemic encephalopathy in patients with multiple myeloma may be associated with the appearance of peripheral blood myeloma cells.

Authors:  Junji Ikewaki; Masao Ogata; Tomoyuki Imamura; Kazuhiro Kohno; Toshiyuki Nakayama; Jun-Ichi Kadota
Journal:  Leuk Lymphoma       Date:  2009-04

Review 5.  Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortality.

Authors:  Anthony Pham; John L Reagan; Jorge J Castillo
Journal:  Leuk Res       Date:  2013-08-06       Impact factor: 3.156

Review 6.  Multiple myeloma and hyperammonemic encephalopathy: review of 27 cases.

Authors:  Jaime Lora-Tamayo; Xavier Palom; José Sarrá; Oriol Gasch; Virginia Isern; Alberto Fernández de Sevilla; Ramón Pujol
Journal:  Clin Lymphoma Myeloma       Date:  2008-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.